公司資料
Theseus Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- THRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for THRX.
公司概覽
業務概覽
Theseus Pharmaceuticals is a precision-oncology company focused on next-generation kinase inhibition and targeted cancer therapy. The company aims to build differentiated assets in genetically defined tumors.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Theseus sits in specialty oncology biotechnology.
商業模式特徵
The business depends on clinical proof, target selectivity, and the ability to create a focused oncology franchise.
生技產業定位
Theseus is a small-cap oncology catalyst name where early data can materially reshape the story.
未來催化劑
- Theseus Pharmaceuticals's catalysts are its kinase-inhibitor programs and any strategy update that clarifies the company's next path forward. The company still needs a clearer development road map.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。